Intrathecal therapy for cancer and non-cancer pain

Pain Physician

Volumn 14, Issue 3, 2011, Pages 219-248

  Hayek, Salim M ^a   Deer, Timothy R ^b   Pope, Jason E ^c   Panchal, Sunil J ^d   Patel, Vikram ^e  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b Center for Pain Relief   (United States)

^c Napa Pain Institute   (United States)

^d National Institute of Pain   (United States)

^e ACMI Pain Care   (United States)

Author keywords

Baclofen infusion; Intra spinal infusion devices; Intraspinal infusion; Intrathecal drug delivery device; Intrathecal drug delivery system; Intrathecal infusion; Intrathecal opioids; Programmable infusion systems; Spinal infusion

Indexed keywords

ANALGESIC AGENT; BACLOFEN; BUPIVACAINE; BUPRENORPHINE; CLONIDINE; FENTANYL; HYDROMORPHONE; LOCAL ANESTHETIC AGENT; METHADONE; MIDAZOLAM; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA CONOTOXIN MVIIA; OPIATE; SUFENTANIL;

ANTINOCICEPTION; BACKACHE; CANCER PAIN; CANCER PATIENT; CHRONIC PAIN; CONFUSION; CONSTIPATION; DRUG DELIVERY SYSTEM; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG IMPLANTATION; DRUG SAFETY; DRUG WITHDRAWAL; FUNCTIONAL STATUS; GRANULOMA; HUMAN; INFECTION; INTRATHECAL DRUG ADMINISTRATION; LEG EDEMA; LEG PAIN; LIQUORRHEA; LOW BACK PAIN; MECHANICAL STRESS; MENINGITIS; METHODOLOGY; MOTOR DYSFUNCTION; MYELITIS; NAUSEA; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARESTHESIA; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; PERIPHERAL EDEMA; PRURITUS; PSYCHOLOGICAL ASPECT; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUALITY OF LIFE; RADICULAR PAIN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SPASTICITY; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; URINE RETENTION; VISUAL ANALOG SCALE; WORK RESUMPTION; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

ANALGESICS; EVIDENCE-BASED MEDICINE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; NEOPLASMS; PAIN, INTRACTABLE; POSTOPERATIVE COMPLICATIONS;

EID: 79957804553     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (168)

1. Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science 1976; 192:1357-1358.
2. Atweh SF, Kuhar MJ. Autoradiograph-ic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res 1977; 124:53-67.
3. Belverud S, Mogilner A, Schulder M. Intrathecal pumps. Neurotherapeutics 2008; 5:114-122.
4. Krames ES. Intrathecal infusional therapies for intractable pain: Patient management guidelines. J Pain Symptom Manage 1993; 8:36-46.
5. Manchikanti L, Boswell MV, Singh V, Benyamin RM, Fellows B, Abdi S, Buenaventura RM, Conn A, Datta S, Derby R, Falco FJE, Erhart S, Diwan S, Hayek SM, Helm S, Parr AT, Schultz DM, Smith HS, Wolfer LR, Hirsch JA. Comprehensive evidence-based guidelines for in-terventional techniques in the management of chronic spinal pain. Pain Physician 2009; 12:699-802.
6. Manchikanti L, Boswell MV, Datta S, Fellows B, Abdi S, Singh V, Benyamin RM, Falco FJE, Helm S, Hayek S, Smith HS. Comprehensive review of therapeutic interventions in managing chronic spinal pain. Pain Physician 2009; 12:E123-E198.
7. Manchikanti L, Helm S, Singh V, Benya-min RM, Datta S, Hayek S, Fellows B, Boswell MV. An algorithmic approach for clinical management of chronic spinal pain. Pain Physician 2009; 12:E225-E264.
8. Gupta A, Mehdi A, Duwell M, Sinha A. Evidence-based review of the pharma-coeconomics related to the management of chronic nonmalignant pain. J Pain Palliat Care Pharmacother 2010; 24:152-156.
9. Manchikanti L, Singh V, Datta S, Cohen SP, Hirsch JA. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician 2009; 12:E35-E70.
10. Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 2008; 8:8-20.
11. Deyo RA, Mirza SK, Turner JA, Martin BI. Overtreating chronic back pain: Time to back off? J Am Board Fam Med 2009; 22:62-68.
12. Peng PW, Fedoroff I, Jacques L, Kumar K. Survey of the practice of spinal cord stimulators and intrathecal analgesic delivery implants for management of pain in Canada. Pain Res Manag 2007; 12:281-285.
13. Deer TR, Kim C, Bowman R, Tolentino D, Stewart C, Tolentino W. Intrathecal zi-conotide and opioid combination therapy for noncancer pain: An observational study. Pain Physician 2009; 12:E291-E296.
14. Raffaeli W, Sarti D, Demartini L, Sotgiu A, Bonezzi C; Italian Ziconotide Group. Italian registry on long-term intrathe-cal ziconotide treatment. Pain Physician 2011; 14:15-24.
15. Lawson EF, Wallace MS. Current developments in intraspinal agents for cancer and noncancer pain. Curr Pain Headache Rep 2010; 14:8-16.
16. Bennett G, Burchiel K, Buchser E, Classen A, Deer T, Du Pen S, Ferrante FM, Hassenbusch SJ, Lou L, Maeyaert J, Penn R, Portenoy RK, Rauck R, Serafi-ni M, Willis KD, Yaksh T. Clinical guidelines for intraspinal infusion: Report of an expert panel. PolyAnalgesic Consensus Conference 2000. J Pain Symptom Manage 2000; 20:S37-43.
17. Deer TR, Smith HS, Cousins M, Do-leys DM, Levy RM, Rathmell JP, Staats PS, Wallace M, Webster LR. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician 2010; 13:E175-213.
18. Deer T, Krames ES, Hassenbusch SJ, Burton A, Caraway D, Dupen S, Eisenach J, Erdek M, Grigsby E, Kim P, Levy R, McDowell G, Mekhail N, Panchal S, Prager J, Rauck R, Saulino M, Sitzman T, Staats P, Stanton-Hicks M, Stearns L, Willis KD, Witt W, Follett K, Huntoon M, Liem L, Rathmell J, Wallace M, Bu-chser E, Cousins M, Ver Donck A. Poly-analgesic Consensus Conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation 2007; 10:300-328.
19. Hassenbusch SJ, Portenoy RK, Cousins M, Buchser E, Deer TR, Du Pen SL, Eisenach J, Follett KA, Hildebrand KR, Krames ES, Levy RM, Palmer PP, Rathmell JP, Rauck RL, Staats PS, Stearns L, Willis KD. Polyanalgesic Consensus Conference 2003: An update on the management of pain by intraspinal drug delivery-- report of an expert panel. J Pain Symptom Manage 2004; 27:540-563.
20. Duse G, Davia G, White PF. Improvement in psychosocial outcomes in chronic pain patients receiving intra-thecal morphine infusions. Anesth Analg 2009; 109:1981-1986.
21. Ilias W, le Polain B, Buchser E, Demar-tini L. Patient-controlled analgesia in chronic pain patients: Experience with a new device designed to be used with implanted programmable pumps. Pain Pract 2008; 8:164-170.
22. Deer T, Chapple I, Classen A, Javery K, Stoker V, Tonder L, Burchiel K. Intrathe-cal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain. Pain Med 2004; 5:6-13.
23. Dewilde S, Verdian L, Maclaine GD. Cost-effectiveness of ziconotide in in-trathecal pain management for severe chronic pain patients in the UK. Curr Med Res Opin 2009; 25:2007-2019.
24. Patel VB, Manchikanti L, Singh V, Schul-tz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12:345-360.
25. Kumar K, Hunter G, Demeria DD. Treatment of chronic pain by using intrathe-cal drug therapy compared with conventional pain therapies: A cost-effectiveness analysis. J Neurosurg 2002; 97:803-810.
26. Hassenbusch SJ, Paice JA, Patt RB, Bed-der MD, Bell GK. Clinical realities and economic considerations: Economics of intrathecal therapy. J Pain Symptom Manage 1997; 14:S36-S48.
27. de Lissovoy G, Brown RE, Halpern M, Hassenbusch SJ, Ross E. Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. Clin Ther 1997; 19:96-112.
28. Smith TJ, Coyne PJ. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients. J Palliat Med 2005; 8:736-742.
29. Turner JA, Sears JM, Loeser JD. Programmable intrathecal opioid delivery systems for chronic non-malignant pain: A systematic review of effectiveness and complications. Clin J Pain 2007; 23:180-195.
30. Noble M, Treadwell J, Schoelles K, Sun F. Health Technology Assessment, Washington State Health Care Authority. Implantable Infusion Pumps for Chronic Noncancer Pain. ECRI Institue, July 18, 2008. www.hta.hca.wa.gov/documents/im-plantable_infusion_pumps_final.pdf
31. Farrar JT, Young JP, Jr., LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94:149-158.
32. West S, King V, Carey TS, Lohr KN, McK-oy N, Sutton SF, Lux L. Systems to Rate the Strength of Scientific Evidence. Evidence Report/Technology Assessment No. 47. AHRQ Publication No. 02-E016. Agency for Healthcare Research and Quality, Rockville, MD, 2002.
33. Manchikanti L, Singh V, Smith HS, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 4: Observational studies. Pain Physician 2009; 12:73-108.
34. Manchikanti L, Datta S, Smith HS, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 6: Systematic reviews and meta-analyses of observational studies. Pain Physician 2009; 12:819-850.
35. Koes BW, Scholten RJ, Mens JM, Bout-Er LM. Efficacy of epidural steroid injections for low-back pain and sciatica: A systematic review of randomized clinical trials. Pain 1995; 63:279-288.
36. Koes BW, Scholten RJ, Mens JMA, Bout-Er LM. Epidural steroid injections for low back pain and sciatica. An updated systematic review of randomized clinical trials. Pain Digest 1999; 9:241-247.
37. Nelemans P, de Bie R, de Vet H, Stur-Mans F. WITHDRAWN: Injection therapy for subacute and chronic benign low-back pain. Cochrane Database Syst Rev 2007; 3:CD001824.
38. Staal JB, de Bie RA, de Vet HC, Hildeb-randt J, Nelemans P. Injection therapy for subacute and chronic low back pain: An updated Cochrane review. Spine (Phi-la Pa 1976) 2009; 34:49-59.
39. Staal JB, de Bie R, de Vet HC, Hildeb-randt J, Nelemans P. Injection therapy for subacute and chronic low-back pain. Cochrane Database Syst Rev 2008; 3:CD001824.
40. Manchikanti L, Hirsch JA, Smith HS. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 2: Randomized controlled trials. Pain Physician 2008; 11:717-773.
41. Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in in-terventional pain management: Part 3: Systematic reviews and meta-analysis of randomized trials. Pain Physician 2009; 12:35-72.
42. Manchikanti L, Derby R, Wolfer LR, Singh V, Datta S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 5: Diagnostic accuracy studies. Pain Physician 2009; 12:517-540.
43. Manchikanti L, Datta S, Derby R, Wolfer LR, Benyamin RM, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for intervention-al techniques: Part 1. Diagnostic interventions. Pain Physician 2010; 13:E141-E174.
44. Benyamin RM, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician 2009; 12:137-157.
45. Buenaventura RM, Datta S, Abdi S, Smith HS. Systematic review of therapeutic lumbar transforaminal epidural steroid injections. Pain Physician 2009; 12:233-251.
46. Conn A, Buenaventura RM, Datta S, Abdi S, Diwan S. Systematic review of caudal epidural injections in the management of chronic low back pain. Pain Physician 2009; 12:109-135.
47. Manchikanti L, Dunbar EE, Wargo BW, Shah RV, Derby R, Cohen SP. Systematic review of cervical discography as a diagnostic test for chronic spinal pain. Pain Physician 2009; 12:305-321.
48. Epter RS, Helm S, 2nd, Hayek SM, Be-nyamin RM, Smith HS, Abdi S. Systematic review of percutaneous adhesiolysis and management of chronic low back pain in post lumbar surgery syndrome. Pain Physician 2009; 12:361-378.
49. Frey ME, Manchikanti L, Benyamin RM, Schultz DM, Smith HS, Cohen SP. Spinal cord stimulation for patients with failed back surgery syndrome: A systematic review. Pain Physician 2009; 12:379-397.
50. Gerges FJ, Lipsitz SR, Nedeljkovic SS. A systematic review on the effectiveness of the Nucleoplasty procedure for disco-genic pain. Pain Physician 2010; 13:117-132.
51. Hayek SM, Helm S, Benyamin RM, Singh V, Bryce DA, Smith HS. Effectiveness of spinal endoscopic adhesiolysis in post lumbar surgery syndrome: A systematic review. Pain Physician 2009; 12:419-435.
52. Helm S, Hayek SM, Benyamin RM, Manchikanti L. Systematic review of the effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician 2009; 12:207-232.
53. Manchikanti L, Derby R, Benyamin RM, Helm S, Hirsch JA. A systematic review of mechanical lumbar disc decompression with nucleoplasty. Pain Physician 2009; 12:561-572.
54. Manchikanti L, Glaser SE, Wolfer L, Derby R, Cohen SP. Systematic review of lumbar discography as a diagnostic test for chronic low back pain. Pain Physician 2009; 12:541-559.
55. Parr AT, Diwan S, Abdi S. Lumbar inter-laminar epidural injections in managing chronic low back and lower extremity pain: A systematic review. Pain Physician 2009; 12:163-188.
56. Singh V, Benyamin RM, Datta S, Fal-co FJ, Helm S, 2nd, Manchikanti L. Systematic review of percutaneous lumbar mechanical disc decompression utilizing Dekompressor. Pain Physician 2009; 12:589-599.
57. Singh V, Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Percutaneous lumbar laser disc decompression: A systematic review of current evidence. Pain Physician 2009; 12:573-588.
58. Falco FJE, Erhart S, Wargo BW, Bryce DA, Atluri S, Datta S, Hayek SM. Systematic review of diagnostic utility and therapeutic effectiveness of cervical facet joint interventions. Pain Physician 2009; 12:323-344.
59. Datta S, Lee M, Falco FJE, Bryce DA, Hayek SM. Systematic assessment of diagnostic accuracy and therapeutic utility of lumbar facet joint interventions. Pain Physician 2009; 12:437-460.
60. Smith HS, Chopra P, Patel VB, Frey ME, Rastogi R. Systematic review on the role of sedation in diagnostic spinal inter-ventional techniques. Pain Physician 2009; 12:195-206.
61. Rupert MP, Lee M, Manchikanti L, Dat-ta S, Cohen SP. Evaluation of sacroili-ac joint interventions: A systematic appraisal of the literature. Pain Physician 2009; 12:399-418.
62. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 1. Basic considerations. Pain Physician 2010; 13:E23-E54.
63. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 2. Implications for interventional pain management. Pain Physician 2010; 13:E55-E79.
64. Manchikanti L, Datta S, Gupta S, Mung-lani R, Bryce DA, Ward SP, Benyamin RM, Sharma ML, Helm II S, Fellows B, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 2. Therapeutic interventions. Pain Physician 2010; 13:E215-E264.
65. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force. Am J Prevent Med 2001; 20:21-35.
66. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schunemann H. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians Task Force. Chest 2006; 129:174-181.
67. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999; 44:289-300.
68. Atli A, Theodore BR, Turk DC, Loeser JD. Intrathecal opioid therapy for chronic nonmalignant pain: A retrospective cohort study with 3-year follow-up. Pain Med 2010; 11:1010-1016.
69. Deer TR, Caraway DL, Kim CK, Dempsey CD, Stewart CD, McNeil KF. Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine. Spine J 2002; 2:274-278.
70. Doleys DM, Brown JL, Ness T. Multidimensional outcomes analysis of intra-thecal, oral opioid, and behavioral-functional restoration therapy for failed back surgery syndrome: A retrospective study with 4 years follow-up. Neuromodulation 2006; 9:270-283.
71. Dominguez E, Sahinler B, Bassam D, Day M, Lou L, Racz G, Raj P. Predictive value of intrathecal narcotic trials for long-term therapy with implantable drug administration systems in chronic non-cancer pain patients. Pain Pract 2002; 2:315-325.
72. Ellis DJ, Dissanayake S, McGuire D, Charapata SG, Staats PS, Wallace MS, Grove GW, Vercruysse P. Continuous intrathecal infusion of ziconotide for treatment of chronic malignant and nonmalignant pain over 12 months: A prospective, open-label study. Neuro-modulation 2008; 11:40-49.
73. Rainov NG, Heidecke V, Burkert W. Long-term intrathecal infusion of drug combinations for chronic back and leg pain. J Pain Symptom Manage 2001; 22:862-871.
74. Rauck RL, Cherry D, Boyer MF, Kosek P, Dunn J, Alo K. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain 2003; 4:441-447.
75. Roberts LJ, Finch PM, Goucke CR, Price LM. Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain 2001; 5:353-361.
76. Shaladi A, Saltari MR, Piva B, Crest-ani F, Tartari S, Pinato P, Micheletto G, Dall'Ara R. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis. Clin J Pain 2007; 23:511-517.
77. Staats P, Whitworth M, Barakat M, Anderson W, Lilienfeld S. The use of implanted programmable infusion pumps in the management of nonmalignant, chronic low-back pain. Neuromodulation 2007; 10:376-380.
78. Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: A 3-year prospective study. Pain 2004; 109:242-249.
79. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intra-thecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996; 85:458-467.
80. Becker R, Jakob D, Uhle EI, Riegel T, Bertalanffy H. The significance of intra-thecal opioid therapy for the treatment of neuropathic cancer pain conditions. Stereotact Funct Neurosurg 2000; 75:16-26.
81. Penn RD, Paice JA. Chronic intrathecal morphine for intractable pain. J Neuro-surg 1987; 67:182-186.
82. Onofrio BM, Yaksh TL. Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 1990; 72:200-209.
83. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Catala E, Bryce DA, Coyne PJ, Pool GE; Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002; 20:4040-4049.
84. Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR, Mayo M, McGuire D, Ellia D. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: A randomized controlled trial. JAMA 2004; 291:63-70.
85. Mercadante S, Intravaia G, Villari P, Fer-rera P, Riina S, David F, Mangione S. In-trathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain 2007; 23:793-798.
86. Hassenbusch SJ, Pillay PK, Magdinec M, Currie K, Bay JW, Covington EC, To-maszewski MZ. Constant infusion of morphine for intractable cancer pain using an implanted pump. J Neurosurg 1990; 73:405-409.
87. Pasutharnchat K, Tan KH, Abdul Hadi M, Ho KY. Intrathecal analgesia in patients with cancer pain--an audit in a tertiary institution. Ann Acad Med Singapore 2009; 38:943-946.
88. Gestin Y, Vainio A, Pegurier AM. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer. Acta Anaesthesiol Scand 1997; 41:12-17.
89. Devulder J, Ghys L, Dhondt W, Rolly G. Spinal analgesia in terminal care: Risk versus benefit. J Pain Symptom Manage 1994; 9:75-81.
90. Van Dongen RT, Crul BJ, De Bock M. Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: A retrospective analysis of 51 cases. Pain 1993; 55:119-123.
91. Rauck RL, Wallace MS, Leong MS, Minehart M, Webster LR, Charapa-ta SG, Abraham JE, Buffington DE, Ellis D, Kartzinel R. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 2006; 31:393-406.
92. Wallace MS, Charapata SG, Fisher R, Byas-Smith M, Staats PS, Mayo M, Mc-Guire D, Ellis D. Intrathecal ziconotide in the treatment of chronic nonmalig-nant pain: A randomized, double-blind, placebo-controlled clinical trial. Neuro-modulation 2006; 9:75-86.
93. Deer TR, Penn R, Kim CK, Bowman RG, Norris M, Stewart CD, Garten TG, To-lentino W, Khan Y. The use of continuous intrathecal infusion of octreotide in patients with chronic pain of noncan-cer origin: An evaluation of efficacy in a prospective double-blind fashion. Neu-romodulation 2006, 9:284-289.
94. Paice JA, Penn RD, Kroin JS. Intrathecal octreotide for relief of intractable non-malignant pain: 5-year experience with two cases. Neurosurgery 1996; 38:203-207.
95. Hassenbusch SJ, Stanton-Hicks M, Cov-ington EC, Walsh JG, Guthrey DS. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995; 10:527-543.
96. Angel IF, Gould HJ, Jr., Carey ME. Intra-thecal morphine pump as a treatment option in chronic pain of nonmalignant origin. Surg Neurol 1998; 49:92-98.
97. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: Long-term benefits and efficacy. Surg Neurol 2001; 55:79-86.
98. Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage 2008; 35:214-228.
99. Simpson B, Middleton P, Maddern G. The Royal Australasian College of Surgeons Implantable spinal infusion devices for chronic pain and spasticity: An accelerated systematic review. ASER-NIP-S REPORT NO. 2003; 42, 1-50.
100. Waara-Wolleat KL, Hildebrand KR, Stewart GR. A review of intrathecal fen-tanyl and sufentanil for the treatment of chronic pain. Pain Med 2006; 7:251-259.
101. Williams JE, Louw G, Towlerton G. In-trathecal pumps for giving opioids in chronic pain: A systematic review. Health Technol Assess 2000; 4:iii-iv,1-65.
102. Bernards CM. Recent insights into the pharmacokinetics of spinal opioids and the relevance to opioid selection. Curr Opin Anaesthesiol 2004; 17:441-447.
103. Bernards CM. Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathe-cal infusion in pigs. Anesthesiology 2006; 105:169-178.
104. van Dongen RT, Crul BJ, van Egmond J. Intrathecal coadministration of bupiva-caine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. Clin J Pain 1999; 15:166-172.
105. Ackerman LL, Follett KA, Rosenquist RW. Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Manage 2003; 26:668-677.
106. Siddall PJ, Molloy AR, Walker S, Mather LE, Rutkowski SB, Cousins MJ. The efficacy of intrathecal morphine and cloni-dine in the treatment of pain after spinal cord injury. Anesth Analg 2000; 91:1493-1498.
107. Webster LR, Fakata KL, Charapata S, Fisher R, MineHart M. Open-label, multicenter study of combined intra-thecal morphine and ziconotide: Addition of morphine in patients receiving ziconotide for severe chronic pain. Pain Med 2008; 9:282-290.
108. Wallace MS, Kosek PS, Staats P, Fisher R, Schultz DM, Leong M. Phase II, open-label, multicenter study of combined in-trathecal morphine and ziconotide: Addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. Pain Med 2008; 9:271-281.
109. Wallace MS, Rauck RL, Deer T. Zi-conotide combination intrathecal therapy: Rationale and evidence. Clin J Pain 2010; 26:635-644.
110. Mironer YE, Haasis JC, Chapple I, Brown C, Satterthwaite JR. Efficacy and safety of intrathecal opioid/bupivacaine mixture in chronic nonmalignant pain: A double blind, randomized, crossover, multicenter study by the National Forum of Independent Pain Clinicians (NFIPC). Neuromodulation 2002; 5:208-213.
111. Kaneko M, Saito Y, Kirihara Y, Collins JG, Kosaka Y. Synergistic antinociceptive interaction after epidural coadministra-tion of morphine and lidocaine in rats. Anesthesiology 1994; 80:137-150.
112. Saito Y, Kaneko M, Kirihara Y, Sakura S, Kosaka Y. Interaction of intrathecally infused morphine and lidocaine in rats (Part I): Synergistic antinociceptive effects. Anesthesiology 1998; 89:1455-1463.
113. Dahm P, Nitescu P, Appelgren L, Cure-laru I. Efficacy and technical complications of long-term continuous intraspi-nal infusions of opioid and/or bupiva-caine in refractory nonmalignant pain: A comparison between the epidural and the intrathecal approach with externalized or implanted catheters and infusion pumps. Clin J Pain 1998; 14:4-16.
114. Buchser E, Durrer A, Chedel D, Musta-ki JP. Efficacy of intrathecal bupivacaine: How important is the flow rate? Pain Med 2004; 5:248-252.
115. Kumar K, Bodani V, Bishop S, Tracey S. Use of intrathecal bupivacaine in refractory chronic nonmalignant pain. Pain Med 2009; 10:819-828.
116. van Dongen RT, van Ee R, Crul BJ. Neurological impairment during long-term intrathecal infusion of bupivacaine in cancer patients: A sign of spinal cord compression. Pain 1997; 69:205-209.
117. Flack SH, Bernards CM. Cerebrospinal fluid and spinal cord distribution of hy-perbaric bupivacaine and baclofen during slow intrathecal infusion in pigs. An-esthesiology 2010; 112:165-173.
118. Mercadante S, Arcuri E, Ferrera P, Villari P, Mangione S. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage 2005; 30:485-491.
119. Dahm P, Nitescu P, Appelgren L, Cure-laru I. High thoracic/low cervical, long-term intrathecal (I.T.) infusion of bupi-vacaine alleviates "refractory" pain in patients with unstable angina pecto-ris. Report of 2 cases. Acta Anaesthesiol Scand 1998; 42:1010-1017.
120. Coffey RJ, Owens ML, Broste SK, Dubois MY, Ferrante FM, Schultz DM, Stearns LJ, Turner MS. Mortality associated with implantation and management of in-trathecal opioid drug infusion systems to treat noncancer pain. Anesthesiology 2009; 111:881-891.
121. Coffey RJ, Owens ML, Broste SK, Dubois MY, Ferrante FM, Schultz DM, Stearns LJ, Turner MS. Medical practice perspective: Identification and mitigation of risk factors for mortality associated with in-trathecal opioids for non-cancer pain. Pain Med 2010; 11:1001-1009.
122. Allen JW, Horais KA, Tozier NA, Wegn-er K, Corbeil JA, Mattrey RF, Rossi SS, Yaksh TL. Time course and role of morphine dose and concentration in intra-thecal granuloma formation in dogs: A combined magnetic resonance imaging and histopathology investigation. Anes-thesiology 2006; 105:581-589.
123. Allen JW, Horais KA, Tozier NA, Yaksh TL. Opiate pharmacology of intrathe-cal granulomas. Anesthesiology 2006; 105:590-598.
124. Blount JP, Remley KB, Yue SK, Erickson DL. Intrathecal granuloma complicating chronic spinal infusion of morphine. Report of three cases. J Neurosurg 1996; 84:272-276.
125. Cabbell KL, Taren JA, Sagher O. Spinal cord compression by catheter granulo-mas in high-dose intrathecal morphine therapy: Case report. Neurosurgery 1998; 42:1176-1180.
126. Coffey RJ, Burchiel K. Inflammatory mass lesions associated with intrathecal drug infusion catheters: Report and observations on 41 patients. Neurosurgery 2002; 50:78-86.
127. Miele VJ, Price KO, Bloomfield S, Hogg J, Bailes JE. A review of intrathecal morphine therapy related granulomas. Eur J Pain 2006; 10:251-261.
128. Zacest AC, Carlson JD, Nemecek A, Bur-chiel KJ. Surgical management of spinal catheter granulomas: Operative nuances and review of the surgical literature. Neurosurgery 2009; 65:1161-1164.
129. Deer TR. A prospective analysis of intra-thecal granuloma in chronic pain patients: A review of the literature and report of a surveillance study. Pain Physician 2004; 7:225-228.
130. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Ann Intern Med 2007; 147:W163-W194.
131. von Elm E, Altman DG, Egger M, Po-cock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Ann Intern Med 2007; 147:573-577.
132. Healy D. Randomized controlled trials: Evidence biased psychiatry. Alliance for Human Research Protection, 2002. www.ahrp.org/COI/healy0802.php
133. Glasziou P, Vandenbroucke JP, Chalmers I. Assessing the quality of research. BMJ 2004; 328:39-41.
134. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312:1215-1218.
135. Funai EF, Rosenbush EJ, Lee MJ, Del Priore G. Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest 2001; 51:8-11.
136. Scales CD Jr., Norris RD, Peterson BL, Preminger GM, Dahm P. Clinical research and statistical methods in the urology literature. J Urol 2005; 174:1374-1379.
137. Greene T. Are observational studies "just as effective" as randomized clinical trials? Blood Purif 2000; 18:317-322.
138. Papanikolaou PN, Christidi GD, Ioan-nidis JP. Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ 2006; 174:635-641.
139. Guyatt G, Drummond R. Part 1. The basics: Using the medical literature. 1A. Introduction: The philosophy of evidence-based medicine. In: Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. American Medical Association, Chicago, 2002, pp 3-12.
140. Hempel CG. Philosophy of Natural Science. Prentice-Hall, Englewood Cliffs, 1966.
141. Popper KR. The Logic of Scientific Discovery. Cambridge University Press, London, 1958.
142. Altman DG, Schulz KF, Moher D, Egg-er M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134:663-694.
143. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 2006; 295:1152-1160.
144. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG; International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group. Evaluating non-randomised intervention studies. Health Technol Assess 2003; 7:1-173.
145. Pocock SJ, Collier TJ, Dandreo KJ, de Stavola BL, Goldman MB, Kalish LA, Kasten LE, McCormack VA. Issues in the reporting of epidemiological studies: A survey of recent practice. BMJ 2004; 329:883.
146. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001; 323:42-46.
147. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analy-sis of observational studies. BMJ 1998; 316:140-144.
148. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Metaanalysis of observational studies in epidemiology: A proposal for reporting. Metaanalysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-2012.
149. Bero LA, Jadad AR. How consumers and policy makers can use systematic reviews for decision making. Ann Intern Med 1997; 127:37-42.
150. Berlin JA, Rennie D. Measuring the quality of trials. JAMA 1999; 282:1083-1085.
151. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999; 28:1-9.
152. Radford MJ, Foody JM. How do observational studies expand the evidence base for therapy? JAMA 2001; 286:1228-1230.
153. Lee W, Bindman J, Ford T, Glozier N, Moran P, Stewart R, Hotopf M. Bias in psychiatric case-control studies: Literature survey. Br J Psychiatry 2007; 190:204-209.
154. Tooth L, Ware R, Bain C, Purdie DM, Dobson A. Quality of reporting of observational longitudinal research. Am J Epidemiol 2005; 161:280-288.
155. Bogardus ST Jr., Concato J, Feinstein AR. Clinical epidemiological quality in molecular genetic research: The need for methodological standards. JAMA 1999; 281:1919-1926.
156. Verhalen RD. Guidelines for documentation of epidemiologic studies. Am J Epidemiol 1981; 114:609-613.
157. Rennie D. CONSORT revised-improving the reporting of randomized trials. JAMA 285:2006-2007.
158. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Ox-man AD, Moher D; CONSORT group; Pragmatic Trials in Healthcare (Practihc) group. Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ 2008; 337:1223-1226.
159. Hartz A, Bentler S, Charlton M, Lanska D, Butani Y, Soomro GM, Benson K. Assessing observational studies of medical treatments. Emerg Themes Epidemiol 2005; 2:8.
160. Kane RL. Approaching the outcomes question. In: Kane RL (ed). Understanding Health Care Outcomes Research. Aspen Publications, Gaithersburg, 1997, pp 1-15.
161. Farquhar C, Marjoribanks J, Basser R, Hetrick S, Lethaby A. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. Cochrane Database Syst Rev 2005; CD003142.
162. Manchikanti L, Pampati V. Research designs in interventional pain management: Is randomization superior, desirable or essential? Pain Physician 2002; 5:275-284.
163. Carragee EJ, Hurwitz EL, Cheng I, Carroll LJ, Nordin M, Guzman J, Peloso P, Holm LW, Côté P, Hogg-Johnson S, van der Velde G, Cassidy JD, Haldeman S; Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Treatment of neck pain: Injections and surgical interventions: Results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976) 2008; 33:S153-S169.
164. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342:1878-1886.
165. Hartz A, Benson K, Glaser J, Bentler S, Bhandari M. Assessing observational studies of spinal fusion and chemo-nucleolysis. Spine (Phila Pa 1976) 2003; 28:2268-2275.
166. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342:1887-1892.
167. Shrier I, Boivin JF, Steele RJ, Platt RW, Furlan A, Kakuma R, Brophy J, Rossi-gnol M. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol 2007; 166:1203-1209.
168. Deer TR, Krames E, Levy RM, Hassen-busch SJ, 3rd, Prager JP. Practice choices and challenges in the current intrathecal therapy environment: An online survey. Pain Med 2009; 10:304-309.